Literature DB >> 33868659

Jaundice in Polycystic Liver Disease: More Than Meets the Eye.

Danielle Brandman1.   

Abstract

Entities:  

Year:  2021        PMID： 33868659      PMCID： PMC8043709          DOI： 10.1002/cld.1001

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

Review 1.  Clinical management of polycystic liver disease.

Authors:  René M M van Aerts; Liyanne F M van de Laarschot; Jesus M Banales; Joost P H Drenth
Journal:  J Hepatol       Date:  2017-11-24       Impact factor: 25.083

2.  Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

Authors:  Rene M M van Aerts; Wietske Kievit; Hedwig M A D'Agnolo; Charles J Blijdorp; Niek F Casteleijn; Shosha E I Dekker; Johan W de Fijter; Maatje van Gastel; Tom J Gevers; Liyanne F M van de Laarschot; Marten A Lantinga; Monique Losekoot; Esther Meijer; A Lianne Messchendorp; Myrte K Neijenhuis; Michelle J Pena; Dorien J M Peters; Mahdi Salih; Darius Soonawala; Edwin M Spithoven; Folkert W Visser; Jack F Wetzels; Robert Zietse; Ron T Gansevoort; Joost P H Drenth
Journal:  Gastroenterology       Date:  2019-04-22       Impact factor: 22.682

3.  Liver involvement in early autosomal-dominant polycystic kidney disease.

Authors:  Marie C Hogan; Kaleab Abebe; Vicente E Torres; Arlene B Chapman; Kyongtae T Bae; Cheng Tao; Hongliang Sun; Ronald D Perrone; Theodore I Steinman; William Braun; Franz T Winklhofer; Dana C Miskulin; Frederic Rahbari-Oskoui; Godela Brosnahan; Amirali Masoumi; Irina O Karpov; Susan Spillane; Michael Flessner; Charity G Moore; Robert W Schrier
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

4.  Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study.

Authors:  E Levine; L T Cook; J J Grantham
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

5.  Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Authors:  Loes van Keimpema; Frederik Nevens; Ragna Vanslembrouck; Martijn G H van Oijen; Aswin L Hoffmann; Helena M Dekker; Robert A de Man; Joost P H Drenth
Journal:  Gastroenterology       Date:  2009-07-29       Impact factor: 22.682

6.  High incidence of common bile duct dilatation in autosomal dominant polycystic kidney disease patients.

Authors:  I Ishikawa; E Chikamoto; M Nakamura; M Asaka; N Tomosugi; T Yuri
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

Review 7.  Role of primary cilia in the pathogenesis of polycystic kidney disease.

Authors:  Bradley K Yoder
Journal:  J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 10.121

8.  Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences.

Authors:  Louise Barbier; Maxime Ronot; Béatrice Aussilhou; François Cauchy; Claire Francoz; Valérie Vilgrain; Olivier Soubrane; Valérie Paradis; Jacques Belghiti
Journal:  Hepatology       Date:  2018-07-11       Impact factor: 17.425

9.  Obstructive jaundice in polycystic liver disease related to coexisting cholangiocarcinoma.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Charikleia Triantopoulou; Kostantina Paraskeva; Kostas Athanassiou; Christos Dervenis
Journal:  Case Rep Gastroenterol       Date:  2008-05-24

10.  Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.

Authors:  William P Martin; Lisa E Vaughan; Kotaro Yoshida; Naoki Takahashi; Marie E Edwards; Andrew Metzger; Sarah R Senum; Tetyana V Masyuk; Nicholas F LaRusso; Matthew D Griffin; Ziad El-Zoghby; Peter C Harris; Walter K Kremers; David M Nagorney; Patrick S Kamath; Vicente E Torres; Marie C Hogan
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.